Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Neuro-Oncology, EGFRvIII GBM Targeted Therapy

Annick Desjardins

MD, FRCPC

🏢Duke University Medical Center🌐USA

Professor, Department of Neurology

44
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Annick Desjardins has led innovative clinical trials in recurrent GBM, including the landmark study of recombinant oncolytic poliovirus therapy targeting EGFRvIII-expressing GBM. Her work on intratumoral delivery of novel agents has opened new avenues for GBM therapy. She has contributed to understanding patterns of GBM recurrence, pseudo-progression, and response to immunotherapy-based approaches.

Share:

🧪Research Fields 研究领域

EGFRvIII GBM targeting
polio virus oncolytic GBM
GBM recurrence treatment
GBM immunotherapy clinical trials
convection enhanced delivery CNS

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Annick Desjardins 的研究动态

Follow Annick Desjardins's research updates

留下邮箱,当我们发布与 Annick Desjardins(Duke University Medical Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment